ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma

Weng, Chengyin; Wang, Lina; Liu, Guolong*; Guan, Mingmei*; Lu, Lin*1
Frontiers in Oncology2021-11-18DOI: 10.3389/fonc.2021.763027
12被引4阅读
引用收藏
分享

摘要

Backgroundm6A-related lncRNAs emerged as potential targets for tumor diagnosis and treatment. This study aimed to identify m6A-regulated lncRNAs in lung squamous cell carcinoma (LUSC) patients. Materials and MethodsRNA sequencing and the clinical data of LUSC patients were downloaded from The Cancer Genome Atlas (TCGA) database. The m6A-related lncRNAs were identified by using Pearson correlation assay. Univariate and multivariate Cox regression analyses were utilized to construct a risk model. The performance of the risk model was validated using Kaplan-Meier survival analysis and receiver operating characteristics (ROC). Immune estimation of LUSC was downloaded from TIMER, and the correlations between the risk score and various immune cells infiltration were analyzed using various methods. Differences in immune functions and expression of immune checkpoint inhibitors and m6A regulators between high-risk and low-risk groups were further explored. Finally, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were utilized to explore the biological functions of AL122125.1. ResultsA total of 351 m6A-related lncRNAs were obtained from TCGA. Seven lncRNAs demonstrated prognostic values. A further multivariate Cox regression assay constructed a risk model consisting of two lncRNAs (AL122125.1 and HORMAD2-AS1). The Kaplan-Meier analysis and area under the curve indicated that this risk model could be used to predict the prognosis of LUSC patients. The m6A-related lncRNAs were immune-associated. There were significant correlations between risk score and immune cell infiltration, immune functions, and expression of immune checkpoint inhibitors. Meanwhile, there were significant differences in the expression of m6A regulators between the high- and low-risk groups. Moreover, GO and KEGG analyses revealed that the upregulated expression of AL122125.1 was tumor-related. ConclusionIn this study, we constructed an m6A-related lncRNA risk model to predict the survival of LUSC patients. This study could provide a novel insight to the prognosis and treatment of LUSC patients.

学科与关键词

关键词
m6A (N6-methyladenosine)long noncoding RNAlung squamous cell carcinoma (LSCC)prognosisimmune microenvironment
相关
加载中…
  • N6-Methyladenosine (m6A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma
    Zhou, Yang; Guan, Xuhui; Wang, Shuncong; Sun, Huanhuan*; Ma, Haiqing*Journal of Oncology, 2022, 2022: 5240611.
  • Comprehensive Analysis of Immune Cell Infiltration of m6a-Related lncRNA in Lung Squamous Cell Carcinoma and Construction of Relevant Prognostic Models
    Zhang, Pengfei; Li, Huawei; Cheng, Xiaoguang; Wang, Wei*Biomed Research International, 2022, 2022: 9139823.被引 1
  • The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma
    Huang, Hanwen; Wu, Weibin; Lu, Yiyu*; Pan, Xiaofen*Journal of Thoracic Disease, 2022.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2021-11-18
卷期
第 11 卷
页码
763027
DOI
10.3389/fonc.2021.763027
期刊收录
NSL
期刊等级
3区
成果收录
SCIE

作者

  • W

    Weng, Chengyin (第一作者)

    1

  • W

    Wang, Lina

    1

查看全部 5 位作者收起作者
  • L

    Liu, Guolong (通讯)

    1

  • G

    Guan, Mingmei (通讯)

    1

  • L

    Lu, Lin (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417